Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Agronomics Limited | LSE:ANIC | London | Ordinary Share | IM00B6QH1J21 | ORD 0.0001P |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 0.00 | 0.00% | 3.975 | 116,786 | 08:00:00 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 3.95 | 4.00 | 3.975 | 3.975 | 3.975 | |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Investors, Nec | 30.88M | 22.37M | 0.0222 | 1.79 | 40.12M |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 09:05:59 | O | 251 | 3.987 | GBX |
| Date | Time | Source | Headline |
|---|---|---|---|
| 15/10/2024 | 15:36 | UK RNS | Agronomics Limited Agronomics invests US$ 2m in Liberation Labs |
| 15/10/2024 | 13:22 | ALNC |  TRADING UPDATES: Strategic Minerals touts improved Cobre sales |
| 15/10/2024 | 06:00 | UK RNS | Agronomics Limited Agronomics invests US$2m in Liberation Labs |
| 12/10/2024 | 10:34 | ALNC | DIRECTOR DEALINGS: Next brand directors and Greggs finance chief sell |
| 10/10/2024 | 15:20 | UK RNS | Agronomics Limited Jim Mellon – Director’s Dealing and PDMR |
| 08/10/2024 | 10:30 | UK RNS | Agronomics Limited Jim Mellon – Director’s Dealing and PDMR |
| 07/10/2024 | 10:52 | UK RNS | Agronomics Limited Exercise of Warrants & TVR |
| 04/10/2024 | 12:57 | UK RNS | Agronomics Limited Holding(s) in Company |
| 29/9/2024 | 12:08 | ALNC | EXECUTIVE CHANGES: VSA Capital hires finance director from Oberon |
| 27/9/2024 | 06:00 | UK RNS | Agronomics Limited Shellbay Appoints New Chief Executive Officer |
Agronomics (ANIC) Share Charts1 Year Agronomics Chart |
|
1 Month Agronomics Chart |
Intraday Agronomics Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 20/11/2024 | 15:41 | Agronomics -ANIC- Clean shell, Heavyweight Board, Ready for Action | 2,248 |
| 23/8/2024 | 08:44 | precision fermentation and Synthetic milk | 1 |
| 23/8/2024 | 08:20 | AGRONOMICS: A Cellular Agriculture Investment Portfolio | 212 |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|---|---|---|---|
| 09:06:01 | 3.99 | 251 | 10.01 | O |
| 08:49:52 | 4.00 | 100,000 | 4,000.00 | O |
| 08:47:50 | 4.00 | 1,000 | 40.00 | O |
| 08:02:00 | 3.95 | 15,535 | 613.63 | O |
| 2024-11-20 16:19:24 | 3.99 | 25,062 | 999.97 | O |
| Top Posts |
|---|
Posted at 21/11/2024 08:20 by Agronomics Daily Update Agronomics Limited is listed in the Investors, Nec sector of the London Stock Exchange with ticker ANIC. The last closing price for Agronomics was 3.98p.Agronomics currently has 1,009,408,091 shares in issue. The market capitalisation of Agronomics is £40,073,501. Agronomics has a price to earnings ratio (PE ratio) of 1.79. This morning ANIC shares opened at 3.98p |
Posted at 13/11/2024 15:16 by nanopayments You seem to have focused more on the portfolio companies, rather than the share price chris, and I think that's the right thing to do. As long as the underlying companies are making progress towards their goals and profitability, and for the most part that seems to be the case, the share price will ultimately take care of itself. Focusing on the share price leads to hightened emotions, greed when things are going well, and fear when they're going badly, and that generally leads to bad investing decisions. |
Posted at 24/10/2024 12:38 by 1chrism Blind to the tribulations of the ANIC share price, BlueNalu partner Nutreco opens a cell feed production facility in the Nederlands. https://www.aquafeed |
Posted at 21/9/2024 07:19 by 1chrism Whilst it is worth noting that other markets are available and have improved where the UK has not it offers a false promise. The S&P is blue chip so a comparison is apples and oranges.The Russell makes more sense but within that particular bowl of fruit there sits no VC like ANIC. We all know that when it comes to cellular agriculture VCs, there is only one.Your question persists, however. Would it have worked better in the US? Without seeing anything like for like in any etfs or wrappers no certainty can be added to the statement. We do also know that a growing number of US states are banning lab meat - without the concept being rea?ised. But do I think that the UK has saved ANIC from the insanity of US politics, perhaps. The US recently pumped $2m into solar foods. But the UK has put £2bn aside for alternative foods and have a QUANGO working on reforming the process of approvals for alternative proteins. Australia is looking good for this and obviously Singapore leads the pack. Perhaps ANIC would be ripping up the re-ratings book on the Singapore.A handy thing to remind ourselves of is the stage we find ANIC in: all companies who have a revenue have begun within the last 12 months. So if you invest in ANIC you are stepping into the abyss in a way that does not exist on any exchange. I gave myself a 20 year brief two years ago and ANIC have a decade of funding left. This is probably why I would rather ANIC is on the UK rather than US. If you have a short term plan for ANIC then your statement does hold credo. So there is a good place to leave it: UK market for the longhaul, and US for the short term. And speaking of shorts, another week to forget for the share price. |
Posted at 14/9/2024 09:27 by 1chrism He did talk about Lineration Labs at two points in the conversation and was even frank about the timeline (pushing it back to mid '25). Id implore anyone who thinks this to listen again.There was also an awful lot about how impressive fundraising has been in a depressed market ($200m+) in the last year and most of it enabling companies to step towards commercialisation.I do agree with you on sentiment, Liberation Labs delay is a upheaval on the share price (and may already be priced in: despite meatly, despite formo, despite solar foods world changing news it has dipped).We all know it is going to happen, it is just frustrating knowing there will be more stress on the share price even though literally all companies in the portfolio are taking off. Even Umami (which were more or less written down) are an ANIC earner. It's all macro pressure so, as Chow says, point me to an AIM VC and I will show you only a discount. On the whole it is good to know that ANIC know what can and cannot be controlled and importantly that the focus and efforts will not be dimmed (10 years runway helps of course). |
Posted at 11/9/2024 08:46 by davebowler Oak Bloke today...Agronomics also stands out as a holding where the share price has fallen on no bad news and the NAV has remained strong. In fact considering its first holding has now IPO'd (and covers 30% of ANIC's share price, and is up 2.75% today) and its portfolio overall have raised $250m in new funding in the past year (despite the horrendous environment to growth shares), including funding from major industry players like REWE (the "Tesco's of Germany) and working in partnerships with major industry players (like the "Cadbury's" of Japan). It is simply being ignored. |
Posted at 02/9/2024 08:25 by nanopayments The argument is true independently of any gains or losses. Trying to trade, or time short-term market moves is just another form of gambling. The vast majority of daytraders lose money. What people say on message boards, or the day-to-day buying and selling of shares on the LSE won't determine whether the ANIC share price rises or falls in the medium to long-term. That will be driven by the real market, the market for the goods and services that its portfolio companies are selling. |
Posted at 22/7/2024 08:24 by 1chrism Meat focussed BSFA Enterprise for the first time today matched ANIC share price. It lacks the portfolio of Mellon's business and swings wildly. We remain in thrall to macro events. |
Posted at 28/6/2024 10:41 by nanopayments Definitely not my favourite topic. Other than the obvious conflict of interest with Jim Mellon, it's unclear to me what value Shellbay bring to the table. In addition, I don't think the directors counted on a situation like we have today where the NAV continues to rise, while the share price tanks. Anthony Chow stated recently that with current cash burn, they have 10 years of runway, which means he wasn't including cash payments for the performance fee in this assumption. So a continued rise in the NAV (which in all other aspects is a cause for celebration) can only mean more dilution as the performance fee is paid in shares. I don't mind dilution, if it's happening at or above the NAV and more importantly, if the return on capital is higher than the cost of capital (still theoretical until the portfolio companies start being monetised), but I definitely do mind this kind of dilution, especially with the share price at multi-year lows.Most of the portfolio companies will also need to raise more capital and Agronomics is highly unlikely to participate in any more of those rounds unless the share price has a massive jump above NAV. Ergo, more dilution. |
Posted at 26/6/2024 10:32 by 1chrism Some salient points made. It really does make little sense to lean on poor share price performance considering: most if not all companies in the portfolio are not in revenue and have regulatory approval concerns. If the share price was thundering ahead it would be the sign of a pump and dump. And of course ANIC is living like all of us through a no growth period when it comes to fundraisingQue, I do think you have useful things to say on the structure of ANIC but of late you have become a bit circular in your criticism and awkwardly personal in your responses, especially for someone who has displayed the capacity to be rational. But as you note, ADVFN is foc and as such is maybe not the place critical verve.That said, the two new contributors (I think new) seem well focused on the individual challenges of the portfolio companies and their specific area of cellular agriculture. This is hugely useful when thinking about what to focus on re share price target, timelines and threats to growth. |
Posted at 06/6/2024 08:58 by 1chrism I think given the current macro indicators: interest rates, inflation, national and international political instability, the current share price of a venture fund focussing on new tech, the current location and trajectory of the share price is to be expected. If it is still looking this way when fsa approvals happen this/next year and ANIC start talking revenues then I will be joining you on the adjectives. For now, with no revenue, Id just say the share price is to be expected and in a world where everything else is rather expensive, we are getting a buy one get one free and some! |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
